On September 27, 2021 Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, reported that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will participate in a fireside chat hosted by Kristen Kluska, Director, Equity Research, at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 29, 2021 at 8:00AM ET (Press release, Soligenix, SEP 27, 2021, View Source [SID1234590303]). In addition to the fireside chat, Dr. Schaber will be available to participate in virtual one-on-one meetings with those who are registered to attend. A webcast of the live fireside chat will be available following the event, please visit View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

For more information about the Cantor Fitzgerald Global Healthcare Conference, please refer to the conference website at View Source

For further information regarding Soligenix, Inc., please visit the Company’s website at www.soligenix.com.